333 related articles for article (PubMed ID: 32991235)
1. BCG vaccine: a hope to control COVID-19 pandemic amid crisis.
Malik YS; Ansari MI; Ganesh B; Sircar S; Bhat S; Pande T; Vinodhkumar OR; Kumar P; Iqbal Yatoo M; Tiwari R; Touil N; Patel SK; Pathak M; Sharun K; Dhama K
Hum Vaccin Immunother; 2020 Dec; 16(12):2954-2962. PubMed ID: 32991235
[TBL] [Abstract][Full Text] [Related]
2. [Is it possible that BCG vaccine protects against COVID-19?].
van Crevel R; van der Meer JWM; Netea MG
Ned Tijdschr Geneeskd; 2020 Oct; 164():. PubMed ID: 33331729
[TBL] [Abstract][Full Text] [Related]
3. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.
Sharma D
Expert Rev Vaccines; 2021 Sep; 20(9):1051-1057. PubMed ID: 34313516
[TBL] [Abstract][Full Text] [Related]
4. Large-Scale Structure-Based Screening of Potential T Cell Cross-Reactivities Involving Peptide-Targets From BCG Vaccine and SARS-CoV-2.
Tarabini RF; Rigo MM; Faustino Fonseca A; Rubin F; Bellé R; Kavraki LE; Ferreto TC; Amaral Antunes D; de Souza APD
Front Immunol; 2021; 12():812176. PubMed ID: 35095907
[TBL] [Abstract][Full Text] [Related]
5. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
Front Immunol; 2021; 12():801799. PubMed ID: 35222355
[TBL] [Abstract][Full Text] [Related]
6. Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
Covián C; Retamal-Díaz A; Bueno SM; Kalergis AM
Front Immunol; 2020; 11():970. PubMed ID: 32574258
[TBL] [Abstract][Full Text] [Related]
7. A Systems Biology Workflow for Drug and Vaccine Repurposing: Identifying Small-Molecule BCG Mimics to Reduce or Prevent COVID-19 Mortality.
Hajjo R; Tropsha A
Pharm Res; 2020 Oct; 37(11):212. PubMed ID: 33025261
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials.
Gong W; Aspatwar A; Wang S; Parkkila S; Wu X
Expert Rev Vaccines; 2021 Jul; 20(7):857-880. PubMed ID: 34078215
[No Abstract] [Full Text] [Related]
9. The BCG Vaccine for COVID-19: First Verdict and Future Directions.
Gonzalez-Perez M; Sanchez-Tarjuelo R; Shor B; Nistal-Villan E; Ochando J
Front Immunol; 2021; 12():632478. PubMed ID: 33763077
[TBL] [Abstract][Full Text] [Related]
10. An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination.
Khade SM; Yabaji SM; Srivastava J
Prep Biochem Biotechnol; 2021; 51(7):650-658. PubMed ID: 33226885
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic.
Aspatwar A; Gong W; Wang S; Wu X; Parkkila S
Int Rev Immunol; 2022; 41(2):283-296. PubMed ID: 33960271
[TBL] [Abstract][Full Text] [Related]
12. Are BCG-induced non-specific effects adequate to provide protection against COVID-19?
Vashishtha VM
Hum Vaccin Immunother; 2021 Jan; 17(1):88-91. PubMed ID: 32762516
[TBL] [Abstract][Full Text] [Related]
13. Convergence between global BCG vaccination and COVID-19 pandemic.
Islam MZ; Zahan MK; Al-Bari MAA
J Med Virol; 2021 Mar; 93(3):1496-1505. PubMed ID: 32827313
[TBL] [Abstract][Full Text] [Related]
14. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
Charoenlap S; Piromsopa K; Charoenlap C
Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
[TBL] [Abstract][Full Text] [Related]
15. The influence of vaccination against tuberculosis with the Bacillus-Calmette-Guérin(BCG) vaccine on COVID-19 incidence and mortality - review of the literature.
Ręka G; Korzeniowska A; Piecewicz-Szczęsna H
Przegl Epidemiol; 2020; 74(2):290-302. PubMed ID: 33115218
[TBL] [Abstract][Full Text] [Related]
16. Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
Behr MA; Divangahi M; Schurr E
J Infect Dis; 2021 Feb; 223(2):189-191. PubMed ID: 33535239
[TBL] [Abstract][Full Text] [Related]
17. New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?
Gupta PK
Cell Immunol; 2020 Oct; 356():104187. PubMed ID: 32745670
[TBL] [Abstract][Full Text] [Related]
18. Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine.
Nuovo G; Tili E; Suster D; Matys E; Hupp L; Magro C
Ann Diagn Pathol; 2020 Oct; 48():151600. PubMed ID: 32805515
[TBL] [Abstract][Full Text] [Related]
19. The Potential Roles of BCG Vaccine in the Prevention or Treatment of COVID-19.
Wang J; Zhang Q; Wang H; Gong W
Front Biosci (Landmark Ed); 2022 May; 27(5):157. PubMed ID: 35638424
[TBL] [Abstract][Full Text] [Related]
20. Research progress on specific and non-specific immune effects of BCG and the possibility of BCG protection against COVID-19.
Du J; Su Y; Wang R; Dong E; Cao Y; Zhao W; Gong W
Front Immunol; 2023; 14():1118378. PubMed ID: 36798128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
